HMGCR and diabetes mellitus: They compared the effects of lower LDL-C cholesterol levels that were mediated by variants in proprotein convertase subtilisin-kexin type 9 (PCSK9), HMGCR, or both on the risk of cardiovascular events and risk of diabetes in 112,772 participants from 14 studies with use of the MR method.